Conversely, the reduced expression of MUC4 during CRC progression is mirrored by the loss of enhancer activity in all PDOs, as underlined by the absence of active enhancers upstream of MUC4 (Fig. 3e). The gene discussed is MUC4; the disease is colorectal carcinoma.